Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: Two randomized, double-blind, placebo-controlled studies of identical design

Current Medical Research and Opinion

Volumn 25, Issue 5, 2009, Pages 1179-1196

  Malanga, Gerard A ^a,b,g   Ruoff, Gary E ^c   Weil, Arnold J ^d   Altman, Charles A ^e   Xie, Fang ^e   Borenstein, David G ^f  

^a OVERLOOK HOSPITAL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c Westside Family Medical Center   (United States)

^d Non Surgical Orthopaedics PC   (United States)

^e CEPHALON INC   (United States)

^f GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^g NONE   (United States)

Author keywords

Back pain; Cyclobenzaprine; Extended release; Muscle spasm; Neck pain; Skeletal muscle relaxant

Indexed keywords

AMRIX; CYCLOBENZAPRINE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIARRHEA; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG CAPSULE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; EVENING DOSAGE; FATIGUE; FEMALE; HUMAN; LABORATORY TEST; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MUSCLE SPASM; NECK PAIN; NIGHT SLEEP; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TREATMENT RESPONSE; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ALGORITHMS; AMITRIPTYLINE; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; NECK PAIN; PLACEBOS; SPASM; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649392373     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902851753     Document Type: Article

References (39)

1. Bosworth T. Special report: the proper use of muscle relaxants in musculoskeletal pain management. Primary Care 2002;6:1-8
2. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:505-514 (Pubitemid 351664521)
3. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147:478-491 (Pubitemid 351688341)
4. Borenstein DG, Korn S. Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: results of two placebo-controlled trials. Clin Ther 2003;25:1056-1073 (Pubitemid 36532578)
5. Nibbelink DW, Strickland SC, McLean LF, et al. Cyclobenzaprine, diazepam and placebo in the treatment of skeletal muscle spasm of local origin. Clin Ther 1978;1:409-424 (Pubitemid 10220919)
6. Brown BR Jr, Womble J. Cyclobenzaprine in intractable pain syndromes with muscle spasm. JAMA 1978;240:1151-1152 (Pubitemid 9040088)
7. Baratta RR. A double-blind study of cyclobenzaprine and placebo in the treatment of acute musculoskeletal conditions of the low back. Curr Ther Res Clin Exp 1982;32:646-652 (Pubitemid 13193065)
8. Bercel NA. Cyclobenzaprine in the treatment of skeletal muscle spasm in osteoarthritis of the cervical and lumbar spine. Curr Ther Res 1977;22:462-468 (Pubitemid 8196716)
9. Aiken DW. A comparative study of the effects of cyclobenzaprine, diazepam and placebo in the treatment of acute musculoskeletal conditions of the low back. Clinical Evaluation of Flexeril (Cyclobenzaprine HCl/MSD). Minneapolis, MN: Postgraduate Medicine Communications, 1978:34-38
10. Bianchi M. Evaluation of cyclobenzaprine for skeletal muscle spasm of local origin. Clinical Evaluation of Flexeril (Cyclobenzaprine HCl/MSD). Minneapolis, MN: Postgraduate Medicine Communications, 1978:25-29
11. Scheiner JJ. Cyclobenzaprine in the treatment of local muscle spasm. Clinical Evaluation of Flexeril (Cyclobenzaprine HCl/MSD). Minneapolis, MN: Postgraduate Medicine Communications, 1978:39-48
12. Aiken DW. Cyclobenzaprine in the treatment of acute skeletal muscle spasm of local origin. Clinical Evaluation of Flexeril (Cyclobenzaprine HCl/MSD). Minneapolis, MN: Postgraduate Medicine Communications, 1978:30-33
13. Steingard PM, Schilberg WL, Peterson KD. Multiclinic study of a muscle relaxant for treatment of acute musculoskeletal disorders. Osteopath Ann 1980;8:44-58 (Pubitemid 11223070)
14. van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003;Issue 4:CD004252
15. Commissiong JW, Karoum F, Reiffenstein RJ, et al. Cyclobenzaprine: a possible mechanism of action for its muscle relaxant effect. Can J Physiol Pharmacol 1981;59:37-44 (Pubitemid 11096018)
16. Katz WA, Dube J. Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience. Clin Ther 1988;10:216-228
17. Nibbelink DW, Strickland SC. Cyclobenzaprine (Flexeril™): report of a postmarketing surveillance program. Curr Ther Res 1980;28:894-903 (Pubitemid 11210682)
18. Malanga GA. The use of medications in the treatment of low back pain. In: Physical Medicine and Rehabilitation: State of the Art Reviews. Philadelphia, PA: Hanley and Belfus, Inc., 1999:13(3)
19. Malanga G, Wolff E. Evidence-informed management of chronic low back pain with nonsteroidal anti-inflammatory drugs, muscle relaxants, and simple analgesics. Spine J 2008;8:173-184 (Pubitemid 350299281)
20. Malanga GA, Roman S, Nadler SF. Medications in the treatment of whiplash associated disorders. In: Malanga GA, Nadler SF, eds. Whiplash. Philadelphia, PA: Hanley and Belfus, Inc., 2002:339-358
21. Cyclobenzaprine hydrochloride tablets [package insert]. Corona, CA: Watson Laboratories, Inc., 2006
22. Amrix [package insert]. Frazer, PA: Cephalon, Inc., 2007
23. Darwish M, Hellriegel ET, Xie F. Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10mg three times daily in healthy young adults. A randomized, open-label, two-period crossover, single-centre study. Clin Drug Investig 2008;28:793-801
24. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/e/policy/pdf/17c.pdf. [Last accessed 10 October 2008]
25. International Conference on Harmonisation Working Group. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1). Presented at: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; June 10, 1996, Washington, DC
26. Cyclobenzaprine HCl MR Investigator's Brochure. 2nd ed. Richmond, VA: ECR Pharmaceuticals, June 3, 2002
27. Rollings HE, Glassman JM, Soyka JP. Management of acute musculoskeletal conditions. Thoracolumbar strain or sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzaprine hydrochloride. Curr Ther Res 1983;34:917-928
28. McHorney CA, Ware JE Jr, Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66
29. Hodgkins M, Albert D, Daltroy L. Comparing patients' and their physicians' assessments of pain. Pain 1985;23:273-277 (Pubitemid 16200696)
30. Teske K, Daut RL, Cleeland CS. Relationships between nurses' observations and patients' self-reports of pain. Pain 1983;16:289-296
31. Michel A, Kohlmann T, Raspe H. The association between clinical findings on physical examination and self-reported severity in back pain. Results of a population-based study. Spine 1997;22:296-303
32. Grossman SA, Sheidler VR, Swedeen K, et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage 1991;6:53-57
33. McCombe PF, Fairbank JC, Cockersole BC, et al. 1989 Volvo Award in Clinical Sciences. Reproducibility of physical signs in low-back pain. Spine 1989;14:908-918
34. Potter NA, Rothstein JM. Intertester reliability for selected clinical tests of the sacroiliac joint. Phys Ther 1985;65:1671-1675 (Pubitemid 16210927)
35. Staiger TO, Paauw DS, Deyo RA, et al. Imaging studies for acute low back pain. When and when not to order them. Postgrad Med 1999;105:161-6, 171
36. Wasiak R, Kim J, Pransky G. Work disability and costs caused by recurrence of low back pain: longer and more costly than in first episodes. Spine 2006;31:219-225 (Pubitemid 43117713)
37. Waddell G. The clinical course of low back pain. In: The Back Pain Revolution. Edinburgh, UK: Churchill Livingstone, 1998:103-117
38. Browning R, Jackson JL, O'Malley PG. Cyclobenzaprine and back pain: a meta-analysis. Arch Intern Med 2001;161:1613-1620 (Pubitemid 32684566)
39. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984;6:592-599 (Pubitemid 14064945)